Essential Fatty Acids in Prostate Disease
Author Information
Author(s): A. Chaudryl, S. McClinton, L.E.F. Moffat, K.W.J. Wahle
Primary Institution: Aberdeen Royal Infirmary; The Rowett Research Institute
Hypothesis
Differences in the metabolism of essential fatty acids between patients with benign or malignant prostatic disease may help to elucidate their role in cancer.
Conclusion
The concentration of arachidonic acid in malignant prostatic tissue is significantly lower than in benign tissue, likely due to increased metabolism.
Supporting Evidence
- Patients with malignant prostatic disease had a significantly higher concentration of oleic acid in phospholipids from both plasma and prostatic tissue.
- A significant reduction in arachidonic acid and docosapentaenoic acid concentrations was observed in malignant tissue compared to benign.
- The stearic to oleic acid ratio was significantly reduced in malignant tissue.
Takeaway
This study looked at the fats in the blood and tissue of men with prostate problems and found that those with cancer had less of a certain fat that might be important for understanding the disease.
Methodology
Blood and tissue samples were taken from patients undergoing prostatic surgery, and fatty acid concentrations were analyzed using gas chromatography.
Limitations
The study only included a small number of patients (20), which may limit the generalizability of the findings.
Participant Demographics
Patients were men undergoing surgery for benign or malignant prostatic disease.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.002
Want to read the original?
Access the complete publication on the publisher's website